Back to GetFilings.com



Table of Contents



SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


     
(Mark One)    
 
[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 28, 2002

OR

     
[    ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________ to _______________

Commission File Number 000-26519

SEMINIS, INC.

(Exact Name of Registrant as Specified in its Charter)
     
Delaware
(State of Incorporation)
  36-0769130
(I.R.S. Employer Identification No.)
 
2700 Camino del Sol, Oxnard, California
(Address of Principal Executive Offices)
  93030-7967
(Zip Code)

(805) 647-1572
(Registrant’s telephone number, including area code)

Not Applicable
(Former name, address and former fiscal year, if changed since last report)

Indicate, by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES   [X]     NO [   ]

As of July 26, 2002 the Registrant had 18,294,555 registered shares of Class A Common Stock, $0.01 par value per share, issued and outstanding, and 45,142,508 unregistered shares of Class B Common Stock, $0.01 par value per share, issued and outstanding.



 


TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets
Consolidated Statements of Operations
Consolidated Statement of Stockholders’ Equity
Consolidated Statements of Cash Flows
Notes to Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures about Market Risk
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
Item 6. Exhibits and Reports on Form 8-K
Exhibit Index
Signatures
EXHIBIT 99.1
EXHIBIT 99.1


Table of Contents

SEMINIS, INC.

Form 10-Q
For the Quarterly Period Ended June 28, 2002

TABLE OF CONTENTS

         
        Page
       
    PART I — FINANCIAL INFORMATION    
Item 1.   Financial Statements    
    Consolidated Balance Sheets as of June 28, 2002 and September 30, 2001   3
    Consolidated Statements of Operations for the Three and Nine Months Ended June 28, 2002 and June 29, 2001   4
    Consolidated Statement of Stockholders’ Equity for the Nine Months Ended June 28, 2002   5
    Consolidated Statements of Cash Flows for the Nine Months Ended June 28, 2002 and June 29, 2001   6
    Notes to Consolidated Financial Statements   7
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   13
Item 3.   Quantitative and Qualitative Disclosures about Market Risk   19
    PART II — OTHER INFORMATION    
Item 1.   Legal Proceedings   20
Item 6.   Exhibits and Reports on Form 8-K   20
    Signatures   22

2


Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

SEMINIS, INC.
Consolidated Balance Sheets

(In thousands, except per share data)

                         
            As of   As of
            June 28,   September 30,
            2002   2001
           
 
            (unaudited)        
Assets:
               
Current assets
               
 
Cash and cash equivalents
  $ 20,825     $ 22,323  
 
Accounts receivable, net
    160,567       141,691  
 
Other receivable
          20,612  
 
Income tax receivable
    5,899        
 
Inventories
    268,466       279,683  
 
Prepaid expenses and other current assets
    4,332       3,436  
 
   
     
 
     
Total current assets
    460,089       467,745  
Property, plant and equipment, net
    172,663       182,261  
Intangible assets, net
    167,117       169,664  
Other assets
    15,779       15,687  
 
 
   
     
 
 
  $ 815,648     $ 835,357  
 
   
     
 
Liabilities, Mandatorily Redeemable Stock and Stockholders’ Equity:
               
Current liabilities
               
 
Short-term borrowings
  $ 36,891     $ 19,665  
 
Current maturities of long-term debt
    243,096       67,527  
 
Accounts payable
    20,164       45,423  
 
Accrued liabilities
    102,132       89,169  
 
   
     
 
       
Total current liabilities
    402,283       221,784  
Long-term debt
    17,756       248,898  
Deferred income taxes
    20,048       15,736  
Minority interest in subsidiaries
    1,752       1,721  
 
   
     
 
     
Total liabilities
    441,839       488,139  
 
   
     
 
Commitments and contingencies
               
 
Mandatorily redeemable stock
               
   
Class B Redeemable Preferred Stock, $0.01 par value; 25 shares authorized as of June 28, 2002 and September 30, 2001; 25 shares issued and outstanding as of June 28, 2002 and September 30, 2001
    29,000       27,500  
 
 
   
     
 
Total mandatorily redeemable stock
    29,000       27,500  
 
   
     
 
Stockholders’ equity
               
   
Class C Preferred Stock, $0.01 par value; 14 shares authorized as of June 28, 2002 and September 30, 2001; 12 shares issued and outstanding as of June 28, 2002 and September 30, 2001 (Liquidation Value of $138.1 and $129.2 million at June 28, 2002 and September 30, 2001, respectively.)
    1       1  
   
Class A Common Stock, $0.01 par value; 211,000 shares authorized as of June 28, 2002 and September 30, 2001; 18,295 and 14,682 shares issued and outstanding as of June 28, 2002 and September 30, 2001, respectively
    183       147  
   
Class B Common Stock, $0.01 par value; 67,000 shares authorized as of June 28, 2002 and September 30, 2001; 45,142 shares issued and outstanding as of June 28, 2002 and September 30, 2001
    452       452  
   
Additional paid-in capital
    768,744       764,657  
   
Accumulated deficit
    (400,768 )     (397,485 )
   
Accumulated other comprehensive loss
    (23,803 )     (48,054 )
 
 
   
     
 
       
Total stockholders’ equity
    344,809       319,718  
 
   
     
 
 
  $ 815,648     $ 835,357  
 
   
     
 

The accompanying notes are an integral part of these consolidated financial statements.

3


Table of Contents

SEMINIS, INC.
Consolidated Statements of Operations

(In thousands, except per share data)

                                          
        For the Three Months Ended   For the Nine Months Ended
       
 
        June 28,   June 29,   June 28,   June 29,
        2002   2001   2002   2001




        (Unaudited)   (Unaudited)
Net sales
  $ 106,564     $ 106,445     $ 338,952     $ 339,192  
Cost of goods sold
    41,581       96,207       128,325       188,528  
 
   
     
     
     
 
 
Gross profit
    64,983       10,238       210,627       150,664  
 
   
     
     
     
 
Operating expenses
                               
 
Research and development expenses
    10,973       13,258       32,483       39,890  
 
Selling, general and administrative expenses
    43,972       54,709       132,500       146,523  
 
Amortization of intangible assets
    4,236       6,803       12,538       21,105  
 
   
     
     
     
 
   
Total operating expenses
    59,181       74,770       177,521       207,518  
 
   
     
     
     
 
Income (loss) from operations
    5,802       (64,532 )     33,106       (56,854 )
 
   
     
     
     
 
Other income (expense)
                               
 
Interest income
    104       200       346       1,204  
 
Interest expense
    (7,186 )     (11,181 )     (21,530 )     (31,801 )
 
Foreign currency gain (loss)
    2,838       (1,555 )     (1,504 )     (2,110 )
 
Other, net
    1,168       (481 )     6,133       (319 )
 
   
     
     
     
 
 
    (3,076 )     (13,017 )     (16,555 )     (33,026 )
 
   
     
     
     
 
Income (loss) before income taxes
    2,726       (77,549 )     16,551       (89,880 )
Income tax benefit (expense)
    1,538       (29,541 )     (5,944 )     (29,168 )
 
   
     
     
     
 
Net income (loss)
    4,264       (107,090 )     10,607       (119,048 )
 
Preferred stock dividends
    (3,496 )     (3,496 )     (10,423 )     (10,409 )
Additional capital contribution dividends
    (1,164 )     (1,164 )     (3,467 )     (3,163 )
 
   
     
     
     
 
Net loss available for common stockholders
  $ (396 )   $ (111,750 )   $ (3,283 )   $ (132,620 )
 
   
     
     
     
 
Net loss available for common stockholders per common share, basic and diluted
  $ (0.01 )   $ (1.87 )   $ (0.05 )   $ (2.22 )
 
   
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

4


Table of Contents

SEMINIS, INC.
Consolidated Statement of Stockholders’ Equity

(In thousands)

                                                                                   
                                                                      Accumu-        
                                                                      lated Other   Total
      Class C   Class A   Class B   Additional   Accumu-   Compre-   Stock-
      Preferred Stock   Common Stock   Common Stock   Paid-In   lated   hensive   holders’
      Number   Amount   Number   Amount   Number   Amount   Capital   Deficit   Loss   Equity
     
 
 
 
 
 
 
 
 
 
Balance, September 30, 2001
    12     $ 1       14,682     $ 147       45,142     $ 452     $ 764,657     $ (397,485 )   $ (48,054 )   $ 319,718  
 
Comprehensive income
                                                                               
 
Net income (Unaudited)
                                              10,607             10,607  
 
Translation adjustment (Unaudited)
                                                    24,251       24,251  
 
                                                                           
 
 
                                                                            34,858  
Restricted share issuance (Unaudited)
                3,611       36                   4,087                   4,123  
 
Options exercised (Unaudited)
                2                                            
 
Dividends on additional capital contribution (Unaudited)
                                              (3,467 )           (3,467 )
 
Dividends on Redeemable
Preferred Stock (Unaudited)
                                              (1,500 )           (1,500 )
 
Dividends on Class C
Preferred Stock (Unaudited)
                                              (8,923 )           (8,923 )
 
   
     
     
     
     
     
     
     
     
     
 
Balance, June 28, 2002 (Unaudited)
    12     $ 1       18,295     $ 183       45,142     $ 452     $ 768,744     $ (400,768 )   $ (23,803 )   $ 344,809  
 
   
     
     
     
     
     
     
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

5


Table of Contents

SEMINIS, INC.
Consolidated Statements of Cash Flows

(In thousands)

                       
          For the Nine Months Ended
         
          June 28,   June 29,
          2002   2001
         
 
Cash flows from operating activities:
               
 
Net income (loss)
  $ 10,607     $ (119,048 )
 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
               
   
Depreciation and amortization
    23,993       33,643  
   
Deferred income taxes
    3,752       21,557  
   
Inventory write-down
    12,309       69,835  
   
Gain on sale of non-core business
    (4,018 )      
   
Other
    (796 )     5,525  
   
Changes in assets and liabilities:
               
     
Accounts receivable
    (14,942 )     (1,001 )
     
Inventories
    5,198       3,031  
     
Prepaid expenses and other assets
    (3,753 )     151  
     
Current income taxes
    (3,953 )     (19 )
     
Accounts payable
    (25,505 )     (32,131 )
     
Other liabilities
    (448 )     (11,289 )
 
 
   
     
 
   
Net cash provided by (used in) operating activities
    2,444       (29,746 )
 
   
     
 
Cash flows from investing activities:
               
 
Purchases of fixed and intangible assets
    (8,767 )     (7,592 )
 
Proceeds from disposition of assets
    25,758       7,096  
 
Proceeds from sale of non-core business
    17,551        
 
Other
    (569 )     (215 )
 
 
   
     
 
   
Net cash provided by (used in) investing activities
    33,973       (711 )
 
   
     
 
Cash flows from financing activities:
               
 
Proceeds from long-term debt
    1,636       1,395  
 
Repayment of long-term debt
    (56,902 )     (17,352 )
 
Net short-term borrowings
    14,981       8,033  
 
Additional capital contribution
          45,850  
 
 
   
     
 
   
Net cash provided by (used in) financing activities
    (40,285 )     37,926  
 
   
     
 
Effect of exchange rate changes on cash and cash equivalents
    2,370       (599 )
 
   
     
 
Increase in cash and cash equivalents
    (1,498 )     6,870  
 
Cash and cash equivalents, beginning of period
    22,323       22,479  
 
   
     
 
Cash and cash equivalents, end of period
  $ 20,825     $ 29,349  
 
   
     
 

The accompanying notes are an integral part of these consolidated financial statements.

6


Table of Contents

SEMINIS, INC.
Notes to Consolidated Financial Statements

(In Thousands, Except Per Share Data)

NOTE 1 — Summary of Significant Accounting Policies

Description of Business

     Seminis, Inc. (“Seminis”, the “Company”, or “we”) is the largest developer, producer and marketer of vegetable and fruit seeds in the world. The Company is a majority-owned subsidiary of Savia, S.A. de C.V. (“Savia”) and effectively began operations when it purchased the Asgrow Seed Company in December 1994.

Basis of Presentation

     The consolidated financial statements include the accounts of the Company and its majority controlled and owned subsidiaries. Investments in unconsolidated entities, representing ownership interests between 20.0% and 50.0%, are accounted for using the equity method of accounting. All material intercompany transactions and balances have been eliminated in consolidation. Certain reclassifications have been made to prior periods to conform to the current quarter presentation.

     Seminis generally operates on a thirteen week calendar quarter closing on the Friday closest to the natural calendar quarter, except for the fiscal year end which closes on September 30.

     The unaudited consolidated financial statements included herein reflect all adjustments, (consisting only of normal recurring adjustments), that the Company considers necessary for a fair presentation of the results of operations for the interim periods covered and of the financial condition of the Company at the date of the interim balance sheet. The Company’s business is subject to seasonal fluctuation and, therefore, the results of operations for periods less than one year are not necessarily indicative of results which may be expected for any other interim period or for the fiscal year as a whole.

Supplementary Cash Flow Information

                   
      Nine Months Ended
     
      June 28,   June 29,
      2002   2001
     
 
      (Unaudited)
Cash paid for interest
  $ 18,993     $ 29,747  
Cash paid for income taxes
    6,145       7,630  
 
Supplemental non-cash transactions:
               
 
Class C Preferred Stock dividends
    8,923       8,909  
 
Class B Redeemable Preferred Stock dividends
    1,500       1,500  
 
Additional capital contribution dividends
    3,467       3,163  
 
Compensation charge for restricted stock award
    4,359       894  

     On July 3, 2002, we received a $5,899 cash tax refund that resulted from the extension of the net operating loss carryback provisions as provided by the Job Creation and Worker Assistance Act of 2002.

     Effective January 2001, Class C Preferred Stock and additional capital contribution accrue cash dividends at 10% per annum. The syndicated bank agreement, however, precludes the payment of cash dividends.

7


Table of Contents

Net Income (Loss) per Common Share

     Net income (loss) per common share has been computed pursuant to the provisions of Statement of Financial Accounting Standards No. 128, “Earnings per Share.” Basic income (loss) per common share is computed by dividing net income (loss) available for common stockholders by the average number of common shares outstanding during each period. Net income (loss) available for common stockholders represents net income (loss) less preferred stock and additional capital contribution dividends. Diluted net income (loss) per common share reflects the potential dilution that could occur if dilutive securities and other contracts were exercised or converted into common stock or resulted in the issuance of common stock. The following table provides a reconciliation of net income (loss) and sets forth the computation for basic and diluted net income (loss) per share available for common stockholders.

                                   
      Three Months Ended   Nine Months Ended
     
 
      June 28,   June 29,   June 28,   June 29,
      2002   2001   2002   2001
     
 
 
 
      (Unaudited)   (Unaudited)
Numerator for basic and diluted:
                               
Net income (loss)
  $ 4,264     $ (107,090 )   $ 10,607     $ (119,048 )
Preferred stock dividends
    (3,496 )     (3,496 )     (10,423 )     (10,409 )
Additional capital contribution dividends
    (1,164 )     (1,164 )     (3,467 )     (3,163 )
 
   
     
     
     
 
 
Net income (loss) available for common stockholders
  $ (396 )   $ (111,750 )   $ (3,283 )   $ (132,620 )
 
   
     
     
     
 
Denominator — shares:
                               
Weighted average common shares outstanding (basic)
    62,746       59,824       61,619       59,824  
Add: potential common shares:
                       
Less: antidilutive effect of potential common shares
                       
 
   
     
     
     
 
Weighted average common shares outstanding (diluted)
    62,746       59,824       61,619       59,824  
 
   
     
     
     
 
Net income (loss) available for common stockholders per common share:                                
 
Basic and diluted
  $ (0.01 )   $ (1.87 )   $ (0.05 )   $ (2.22 )
 
   
     
     
     
 

     A total of 4.4 million and 1.2 million shares of stock options were excluded from the computation of diluted earnings per share for the three and nine months ended June 28, 2002 and the three and nine months ended June 29, 2001, respectively, due to their antidilutive effect. Included in the 4.4 million shares of stock options for the three and nine months ended June 28, 2002 are 2.6 million shares pending stockholders’ approval.

Recent Accounting Pronouncements

     SFAS No. 142, “Goodwill and Other Intangible Assets” was adopted by the Company as of the beginning of fiscal 2002. SFAS 142 addresses financial accounting and reporting for acquired goodwill and other intangible assets and supersedes APB Opinion No. 17, “Intangible Assets”. It addresses how intangible assets that are acquired individually or with a group of other assets, (but not those acquired in a business combination), should be accounted for in financial statements upon their acquisition. This Statement also addresses how goodwill and other intangible assets should be accounted for after they have been initially recognized in the financial statements. The Company expects no impairment in its goodwill and other intangible assets, and ceased the amortization of goodwill that approximated $9.0 million per year.

     In August 2001, FASB issued SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets.” SFAS No. 144 supersedes SFAS No. 121 but retains many of its fundamental provisions. In addition, SFAS No. 144 expands the scope of discontinued operations to include more disposal transactions. We will adopt SFAS No. 144 as of October 1, 2002; SFAS No. 144 is not expected to have a material effect on our consolidated financial position, results of operations or cash flows.

     In May 2002, the Financial Accounting Standards Board issued SFAS No. 145, “Rescission of SFAS Nos. 4, 44, and 64, Amendment of SFAS No. 13, and Technical Corrections.” Among other things, SFAS No. 145 rescinds various pronouncements regarding extinguishment of debt and allows extraordinary accounting treatment for early extinguishment only when the provisions of Accounting Principles Board Opinion No. 30, “Reporting the Results of Operations-Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequent Occurring Events and Transactions” are met. SFAS No. 145 provisions regarding early extinguishment of debt are generally effective for fiscal

8


Table of Contents

years beginning after May 15, 2002. The Company believes this new standard will not have an impact on its business, consolidated financial position, results of operations or cash flow.

     In June 2002, the Financial Accounting Standards Board issued SFAS No. 146, “Accounting for Costs Associated with Exit or Disposal Activities.” SFAS No. 146 supersedes previous accounting guidance, principally Emerging Issues Task Force Issue No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (Including Certain Costs Incurred in a Restructuring.)”

     SFAS No. 146 requires that the liability for costs associated with an exit or disposal activity be initially measured at fair market value and recognized when the liability is incurred. In periods subsequent to initial measurement, changes to the liability are measured using the credit-adjusted risk-free rate that was used in the initial measurement of the liability recorded. The cumulative effect of a change resulting from revisions either to the timing or the amount of estimated cash flow is recognized as an adjustment to the liability in the period of the change and charged to the same line items in the statement of operations used when the related costs were initially recognized. Under EITF No. 94-3, a liability for an exit cost was recognized at the date of the Company’s commitment to an exit plan.

     The provisions of SFAS No. 146 are required to be applied prospectively to exit or disposal activities initiated after December 31, 2002. The Company believes SFAS No. 146 may affect the timing of recognizing future restructuring costs, as well as the amounts recognized, depending on the nature of the exit or disposal activity and the timing of the related estimated cash flows.

NOTE 2 — Liquidity

     As of September 30, 2000, we were not in compliance with certain covenants of our syndicated credit facility, which gave the lenders the right to accelerate payment of all amounts outstanding under the facility. In December 2000, the lenders granted a waiver with respect to these covenants as of September 30, 2000, December 29, 2000, and March 31, 2001 that extended through April 30, 2001, at which time any defaults would once again arise. As we did not expect to be in compliance with our covenants once the waiver expired, all outstanding borrowings under the credit facility were classified as a current liability as of September 30, 2000.

     In connection with granting the waivers, the lenders agreed to reschedule principal payments within fiscal year 2001. The lenders also accelerated the final maturity of the term loan and the termination date for the revolving credit commitments to June 30, 2002 from June 30, 2004. We were obligated to deliver a financial plan through September 30, 2002, which detailed cash flow projections on a monthly basis as well as proposed alternatives for the refinancing of the syndicated credit facility or recapitalization of the Company.

     In April 2001, we submitted a financial plan to our lenders, detailing operating initiatives that reduced existing infrastructure and working capital requirements. Additionally, the plan identified alternative sources of capital to repay the bank debt within newly defined terms, which may include the sale of non-strategic assets, debt refinancing and additional equity infusions.

     On May 31, 2001, our lenders agreed with the financial plan and the terms to restructure our $310.0 million credit facility. Upon receipt of the amended credit agreement, long-term portions of borrowings were reclassified from current liabilities to long-term debt. Among other things, the amendment extended the final maturity of the credit facility from the previously agreed on date of June 30, 2002 to December 31, 2002, revised principal payment dates under the term loan, instituted a new grid pricing formula to determine interest on borrowings, and revised covenant obligations. Additionally, the amendment requires us to submit monthly reports comparing actual cash flows to projections as well as describing the progress and status of any asset sales.

     Interim principal obligations under the amendment included $19.0 million, $4.0 million, $31.0 million, and $9.0 million due in the first, second, third, and fourth quarters of fiscal year 2002, respectively. As all remaining amounts under the credit facility are due within one year, the $238.7 million of outstanding borrowings under the credit facility have been classified as a current liability as of June 28, 2002.

9


Table of Contents

     We met all required principal and interest payments during fiscal year 2001 and for the nine months ended June 28, 2002, and were in compliance with all of our financial covenants under the amended credit agreement at September 30, 2001, December 28, 2001, March 29, 2002 and June 28, 2002. In October 2001, we completed the sale of an office building in Seoul, South Korea, which generated net proceeds of approximately $20.0 million. We used $19.5 million of the proceeds to pay the scheduled $19.0 million of our syndicated debt in October 2001. We also sold one of our non-core businesses in January 2002, which generated additional proceeds of approximately $17.6 million. We used $13.0 million of the proceeds to prepay our syndicated debt in January 2002 and utilized our operating cash flow to pay the remaining $18.0 million in June 2002. A total of $20.0 million in principal payment was made to the syndicated credit facility in the current quarter. When combined with cash flows expected to be generated from on-going operations and additional proceeds from the sale of non-core assets, we will be able to meet all obligations and covenants under the credit facility through September 30, 2002. We believe we can continue to improve our operating cash flows through aggressive cash collection efforts, disciplined inventory purchases, and lower operating expenses following the global restructuring and optimization plan.

     Whereas we expect to meet our obligations as well as covenant requirements under the amended credit facility through September 30, 2002, we must successfully execute a refinancing or recapitalization plan prior to December 31, 2002 in order to meet the final maturity of the facility. Based on current projections, we will be obligated to pay $229.7 million during the first quarter of fiscal year 2003. We are currently pursuing a refinancing and recapitalization plan which may include negotiation of a new credit facility, placement of new debt securities, and restructuring of our Class C Preferred Stock and additional capital contributions. The Company entered into an exchange agreement with its majority shareholder, Savia S.A. de C.V. as of July 1, 2002 to exchange all of its outstanding Seminis Class C Preferred Stock (including accrued PIK dividends) having a principal value of $120.2 million, Additional Paid-In Capital (including accrued PIK dividends) of $46.7 million and accrued and unpaid cash dividends of $10.0 million into 37.7 million shares of Seminis Class A common stock. The remaining accrued and unpaid cash dividends on the Class C Preferred Stock of $15.0 million will remain due and payable and will be paid in cash by the Company in accordance with the terms of the exchange agreement. On July 3, 2002, the Company received an opinion from UBS Warburg that, as of such date, the number of shares of Class A common stock to be received by Savia in the exchange was fair from a financial point of view to the holders of the Company’s Class A common stock and Class B common stock (in each case other than Savia and its affiliates and other than holders of the Company’s Class B common stock that also hold shares of the Company’s Class B Redeemable preferred stock). The exchange agreement was approved by the Company’s Board of Directors on July 3, 2002, but remains subject to stockholders’ approval. A copy of the opinion of UBS Warburg and a copy of the exchange agreement have been filed as exhibits to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 9, 2002. However, there can be no assurances that we will be able to successfully complete the refinancing and recapitalization plan. Failure to comply with existing covenants which would make the syndicated debt callable, or our inability to obtain adequate financing with reasonable terms prior to December 31, 2002 could have a material adverse impact on our business, results of operations, or financial condition.

NOTE 3 — Global Restructuring and Optimization Plan

     In February 2000, we announced a cost-saving initiative designed to streamline operations, increase utilization of facilities and improve efficiencies. The first phase of the initiative, which commenced in fiscal year 2000, and focused on North American operations, was completed by the end of fiscal year 2001. In June 2001, we commenced the second phase, which was targeted at our global operations and expanded the phase to cover additional headcount reductions and to consolidate our facilities in Holland. We expect the second phase to be completed by the end of our current fiscal year. The key elements to the global restructuring and optimization plan involve:

          reorganizing our ten legacy seed companies into four geographical regions;
 
          selling or consolidating certain operation and production facilities;
 
          reducing headcount that results from the reorganization and from facility consolidation;
 
          rationalizing our product portfolio;
 
          implementing an advanced logistics management information system; and
 
          divesting non-strategic assets.

10


Table of Contents

     In connection with phase one of the global restructuring and optimization plan, we recorded nonrecurring pre-tax charges to operations of approximately $34.4 million for restructuring costs during fiscal year 2000 that included severance and other exit costs, inventory write-downs and costs associated with streamlining our products portfolio. Of this amount, $18.4 million was included in cost of goods sold for inventory write-downs. The remaining $16.0 million was included in selling, general and administrative expenses and consisted primarily of severance costs. The total phase one and initial phase two severance charges related to a planned 600-employee reduction worldwide in both operational and administrative groups.

     As part of the implementation of the expanded second phase of our global optimization plan, we recorded a pre-tax charge of $12.0 million in selling, general and administrative expenses in the third quarter of fiscal year 2001. This charge primarily related to severance and related costs resulting from an additional planned 250-employee reduction worldwide in both operational and administrative groups. Primarily as a result of the global restructuring and optimization plan, we severed 144 and 758 employees in 2000 and 2001, respectively, and an additional 272 employees in the first nine months of fiscal year 2002. We also recorded non-cash inventory write-downs of $58.2 million in cost of goods sold in order to comply with more stringent seed quality standards and to further rationalize our product portfolio from 6,000 to 4,000 varieties. We believe we have established adequate reserves for all of the remaining costs and expenses related to our global restructuring and optimization plan.

     The remaining components of the restructuring accruals are as follows:

                                 
    Balance at                        
    Sept. 30,   Additional   Amounts   Balance at
    2001   Charges   Incurred   June 28, 2002
   
 
 
 
            (Unaudited)   (Unaudited)   (Unaudited)
Severance and related expenses
  $ 11,936     $     $ 7,288     $ 4,648  

     To date, there have been no material adjustments to amounts accrued under the plan.

NOTE 4 — Inventories

     Inventories consist of the following:

                 
    June 28,   September 30,
    2002   2001
   
 
    (Unaudited)        
Seed
  $ 226,873     $ 246,250  
Unharvested crop growing costs
    34,395       25,857  
Supplies
    7,198       7,576  
 
   
     
 
 
  $ 268,466     $ 279,683  
 
   
     
 

NOTE 5 — Seminis, Inc. Stock Award Plan

     During the quarter ended June 29, 2001, we adopted a stock award plan that is subject to stockholder approval. Certain key executives are awarded shares that vest if certain quarterly performance criteria are achieved over an 18-month period. Upon meeting each quarterly goal, the shares awarded become vested. The number of shares of Class A Common Stock eligible to be awarded under this plan is 4.8 million shares. During the first, second and third quarters of fiscal year 2002, we met our performance goals, which resulted in quarterly compensation charges of approximately $1.3 million per quarter for the first and second quarters, and approximately $2.9 million in the third quarter, recorded in selling, general and administrative expenses. As the quarterly goals related to the stock award plan were met in each of the last five quarters, 0.8 million, 0.7 million, 0.7 million, 0.7 million and 0.7 million shares were earned in the third and fourth quarters of fiscal year 2001, and the first, second and third quarters of fiscal year 2002, respectively.

     On December 19, 2001, we received confirmation from NASDAQ that the Company could implement the stock award plan in accordance with NASDAQ rules provided that the stock awards will be forfeited back to the Company if stockholder approval is not obtained. As such, the earned share amounts have been shown as issued shares of Class A Common Stock during the first, second and third quarter of fiscal year 2002. The Company believes that at its stockholders meeting to be held in 2002, its stockholders will approve the stock award plan.

11


Table of Contents

NOTE 6 — Contingencies

     In January 2002, melon growers in Costa Rica notified us that our Dorado melon seeds were infected with Watermelon Fruit Blotch. Growers who purchased the infected Seminis seeds and growers whose crops were infected by the bacteria that spread from crops grown with the infected Seminis seeds have claimed damages against us. The claims related to those growers who purchased Seminis seeds have been settled for approximately $5.8 million, of which, approximately $2.6 million was recovered under our errors and omissions insurance policy and the remainder of the settlement was paid by the Company by July 2002. The claims related to the growers with the infected crops total approximately $5.2 million and we believe these claims are covered under our general liability insurance policy. We have tentatively settled all of these claims and we have advanced approximately $2.1 million to the growers; however, we are unable to finalize the settlement because our general liability insurance carrier has tentatively denied coverage. We are continuing to negotiate with our general liability insurance carrier on this matter. In the event we cannot finalize the settlement, claims could increase above $5.2 million.

NOTE 7 — Subsequent Event

     The Company entered into an exchange agreement with its majority shareholder, Savia S.A. de C.V. as of July 1, 2002 to exchange all of its outstanding Seminis Class C Preferred Stock (including accrued PIK dividends) having a principal value of $120.2 million, Additional Paid-In Capital (including accrued PIK dividends) of $46.7 million and accrued and unpaid cash dividends of $10.0 million into 37.7 million shares of Seminis Class A common stock. The remaining accrued and unpaid cash dividends on the Class C Preferred Stock of $15.0 million will remain due and payable and will be paid in cash by the Company in accordance with the terms of the exchange agreement. On July 3, 2002, the Company received an opinion from UBS Warburg that, as of such date, the number of shares of Class A common stock to be received by Savia in the exchange was fair from a financial point of view to the holders of the Company’s Class A common stock and Class B common stock (in each case other than Savia and its affiliates and other than holders of the Company’s Class B common stock that also hold shares of the Company’s Class B Redeemable preferred stock). The exchange agreement was approved by the Company’s Board of Directors on July 3, 2002, but remains subject to stockholders’ approval. A copy of the opinion of UBS Warburg and a copy of the exchange agreement have been filed as exhibits to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 9, 2002.

12


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following discussion and analysis should be read in conjunction with the consolidated financial statements and notes thereto of the Company included elsewhere herein. The following discussion and analysis contains certain “forward-looking statements” which are subject to certain risks, uncertainties and contingencies which could cause Seminis’ actual business, results of operations or financial condition to differ materially from those expressed in, or implied by, such statements.

Overview

     Seminis is the largest developer, producer and marketer of vegetable and fruit seeds in the world. Seminis produces more than 60 species and 4,000 distinct varieties of vegetable and fruit seeds. Seminis has established a worldwide presence and global distribution network that spans 150 countries with over 50 research and development facilities in 17 countries and production sites in over 25 countries. Seminis is a majority owned subsidiary of Savia, S.A. de C. V. (“Savia”).

     In order to achieve its position as the premier vegetable and fruit seed company, Seminis has completed ten acquisitions since its formation in 1994 and has incurred significant expenses related to the development of its infrastructure, including its human resource capability, information systems, brand marketing teams and its research and development capability. Seminis expenses its investments in research and development and in the creation of its worldwide sales capability. The comparability of Seminis’ results of operations from year to year has also been affected by expenses associated with the global restructuring and optimization plan, the impact of acquisition accounting under purchase accounting principles, interest expense attributable to acquisition financing and exposure to foreign currency fluctuations.

Results of Operations

     The table below sets forth Seminis’ results of operations data expressed as a percentage of net sales.

                                 
    Three Months Ended   Nine Months Ended
   
 
    June 28,   June 29,   June 28,   June 29,
    2002   2001   2002   2001
   
 
 
 
    (Unaudited)   (Unaudited)
Net sales
    100.0 %     100.0 %     100.0 %     100.0 %
 
   
     
     
     
 
Gross profit
    61.0       9.6       62.1       44.4  
Research and development expenses
    10.3       12.4       9.5       11.8  
Selling, general and administrative expenses
    41.3       51.4       39.1       43.2  
Amortization of intangible assets
    4.0       6.4       3.7       6.2  
 
   
     
     
     
 
Income (loss) from operations
    5.4       (60.6 )     9.8       (16.8 )
Interest expense, net
    (6.6 )     (10.3 )     (6.2 )     (9.0 )
Other non-operating income (expense), net
    3.8       (1.9 )     1.3       (0.7 )
 
   
     
     
     
 
Income (loss) before income taxes
    2.6       (72.8 )     4.9       (26.5 )
Income tax benefit (expense)
    1.4       (27.8 )     (1.8 )     (8.6 )
 
   
     
     
     
 
Net income (loss)
    4.0 %     (100.6 )%     3.1 %     (35.1 )%
 
   
     
     
     
 

13


Table of Contents

Nine Months Ended June 28, 2002 Compared with Nine Months Ended June 29, 2001

Net Sales

     Net sales decreased 0.1% to $339.0 million for the nine months ended June 28, 2002 from $339.2 million for the same period ended June 29, 2001. The result was primarily due to $3.1 million of negative currency fluctuations relating to weakness in the Euro, South Korean Won, and Brazilian Real versus the United States Dollar during the nine months ended June 28, 2002, compared to the same period in the prior fiscal year. In addition, the nine months ended June 29, 2001 included incremental net sales of $9.2 million from a non-core business divested in January 2002. In constant dollars, stated at monthly average exchange rates for fiscal year 2001, and excluding the sales of the divested non-core business, sales would have increased 3.2%. This increase was primarily attributable to higher sales of onion, cucumber, tomato, white cabbage, peas and bean varieties in the Europe, Middle East, and Africa region. Also, the North and Central America sales region benefited from increased sales of lettuce, spinach and sweet and hot pepper varieties. The sales increases were primarily attributed to price increases implemented in these respective regions. Overall sales increases were partially offset by decreases in Far East region sales due to weak economic and poor weather conditions and in South American sales due to the economic instability in Argentina. Our business is subject to seasonal fluctuations and, therefore, the sales for the first nine months of a fiscal year are not necessarily indicative of those to be expected in any other interim period, or for an entire fiscal year.

Gross Profit

     Gross profit increased 39.8% to $210.6 million for the nine months ended June 28, 2002 from $150.7 million for the nine months ended June 29, 2001. Gross margin increased to 62.1% for the nine months ended June 28, 2002 from 44.4% for the nine months ended June 29, 2001. The improvement in both gross profit and gross margin included a non-cash inventory write-down of $58.2 million taken during the nine months of fiscal year 2001, related to the global restructuring and optimization plan. Excluding the non-cash inventory write-down, gross margin for the period ended June 29, 2001 would have been 61.6%. The increase was also due to seed price increases within the Europe, Middle East, and Africa and the North and Central America sales regions as well as an improved product mix. Additionally, approximately $2.4 million of freight and handling charge revenue was recognized in net sales during the nine months ended June 28, 2002 in compliance with EITF 00-10, “Accounting for Shipping and Handling Fees and Costs,” with the corresponding expense recorded in selling, general and administrative expenses. In the prior year, such freight and handling charge revenue was netted against the corresponding selling, general and administrative expenses.

Research and Development Expenses

     Research and development expenses decreased 18.6% to $32.5 million for the nine months ended June 28, 2002 from $39.9 million for the nine months ended June 29, 2001. The decrease was primarily due to personnel reductions from the global restructuring and optimization plan and currency fluctuations from research and development operations in Europe, South Korea and Brazil for the first nine months of fiscal year 2002. The decrease was also attributable to an approximate $0.8 million research grant received in Europe which offset research and development expenses during the nine months ended June 28, 2002. In addition, expenses decreased by approximately $0.9 million due to the impact of the divestiture of a non-core business.

Selling, General and Administrative Expenses

     Selling, general and administrative expenses decreased 9.6% to $132.5 million for the nine months ended June 28, 2002 from $146.5 million for the nine months ended June 29, 2001. The decrease was primarily the result of approximately $12.0 million of severance provision, $3.0 million of facility moving costs and $3.8 million of consulting fees due to restructuring initiatives incurred in the first nine months of fiscal year 2001 compared to $0.8 million of consulting fees for restructuring during the same period in fiscal year 2002. Additionally, the decrease was attributable to the elimination of $6.0 million of expenses incurred in the second and third quarters of fiscal year 2001, by a non-core business divested in January 2002, combined with the impact of further headcount reductions following the implementation of the global restructuring and optimization plan. The decrease in expenses was partially offset by a primarily non-cash compensation charge of $5.5 million related to an employee stock award plan recorded during the nine months ended June 28, 2002, with $1.3 million recorded during the same period in the prior fiscal year. Additionally, the decrease in expenses was offset by approximately

14


Table of Contents

$2.4 million of freight and handling charge revenue that was recognized in net sales during the nine months ended June 28, 2002. In the prior year, such freight and handling charge revenue was netted against the corresponding selling, general and administrative expenses.

Amortization of Intangible Assets

     Amortization of intangible assets decreased 40.6% to $12.5 million for the nine months ended June 28, 2002 from $21.1 million for the nine months ended June 29, 2001. The decrease was primarily due to the adoption of SFAS No. 142, “Goodwill and Other Intangible Assets.” The pronouncement requires that periodic amortization of goodwill be ceased, and that annual reviews of the net realizable value of the goodwill need to be performed to determine if an impairment of the goodwill asset value exists. We expect no impairment in goodwill and other intangible assets. Therefore, we recorded no goodwill amortization in accordance with SFAS No. 142 in the first nine months of fiscal year 2002, whereas approximately $6.8 million of goodwill amortization was recorded during the same period of fiscal year 2001. The balance of the decrease was also due to the currency impact from the fluctuation of the South Korean Won on South Korean based intangible assets in the first part of the current fiscal year.

Interest Expense, Net

     Interest expense, net, decreased 30.8% to $21.2 million for the nine months ended June 28, 2002 from $30.6 million for the nine months ended June 29, 2001. The decrease was primarily due to lower average debt balances and interest rates during the first nine months of fiscal year 2002 compared to the same period of the prior fiscal year. During the 12 months ended June 28, 2002, our bank debt balance decreased by approximately $62.1 million.

Other Non-Operating Income (Expense), Net

     We had other non-operating income, including foreign currency gain (loss), net, of $4.6 million for the nine months ended June 28, 2002 as compared to other non-operating expense, net, of $2.4 million for the nine months ended June 29, 2001. Other non-operating income, net, for the nine months ended June 28, 2002 primarily consists of an approximate $4.0 million gain from the sale of a non-core business in January 2002, offset by foreign currency losses of $1.5 million resulting from currency fluctuations in South America and a United States Dollar denominated loan in The Netherlands. Other income, net, also includes gains from non-strategic asset sales in South Korea. Other non-operating expense, net, for the nine months ended June 29, 2001, included a foreign currency loss of $2.1 million and other expense of $0.3 million primarily resulting from the loss on sale of fixed assets.

Income Tax Benefit (Expense)

     Income tax expense was $5.9 million and $29.2 million for the nine months ended June 28, 2002 and June 29, 2001, respectively. The decrease in income tax expense was the result of utilization of net operating loss carryback provisions, the mix of worldwide income tax rates and the establishment of valuation allowances for certain deferred tax assets in fiscal year 2001.

15


Table of Contents

Three Months Ended June 28, 2002 Compared with Three Months Ended June 29, 2001

Net Sales

     Net sales increased 0.1% to $106.6 million for the three months ended June 28, 2002 from $106.4 million for the same period ended June 29, 2001. The increase in sales was partially due to $1.8 million of positive currency fluctuations relating to the strengthening of the Euro and South Korean Won, versus the United States Dollar during the three months ended June 28, 2002, compared to the same period in the prior fiscal year. Partially offsetting the increase in sales, the three months ended June 29, 2001 included net sales of $2.9 million from a non-core business divested in January 2002. In constant United States Dollars, stated at monthly average exchange rates for fiscal year 2001, and excluding the sales of the divested non-core business, sales would have increased 1.4%. This increase was primarily attributable to higher sales of onion, cucumber, tomato, white cabbage, peas and bean varieties in the Europe, Middle East, and Africa region. The sales increases were primarily attributed to price increases implemented in these respective regions. Third quarter sales in the Far East region also compared favorably to the prior year, due to increased demand conditions in South Korea. Overall sales increases were partially offset by decreases in the North and Central America regions due to seasonal demand changes and in South American sales primarily due to the economic instability in Argentina. Our business is subject to seasonal fluctuations and, therefore, the sales for the third quarter of a fiscal year are not necessarily indicative of those to be expected in any other interim period, or for an entire fiscal year.

Gross Profit

     Gross profit increased 534.7% to $65.0 million for the three months ended June 28, 2002 from $10.2 million for the three months ended June 29, 2001. Gross margin increased to 61.0% for the three months ended March 29, 2002 from 9.6% for the three months ended June 29, 2001. The improvement in both gross profit and gross margin included a non-cash inventory write-down of $53.8 million taken in the third quarter of fiscal year 2001, which was part of approximately $58.2 million of inventory write-down charges related to the global restructuring and optimization plan recorded in fiscal year 2001. Excluding the non-cash inventory write-down, gross margin for the three months ended June 29, 2001 would have been 60.2%. The increase was also partly due to seed price increases within the Europe, Middle East, and Africa and the North and Central America sales regions as well as an improved product mix. Additionally, approximately $0.9 million of freight and handling charge revenue was recognized in net sales during the three months ended June 28, 2002 in compliance with EITF 00-10, “Accounting for Shipping and Handling Fees and Costs,” with the corresponding expense recorded in selling, general and administrative expenses. In the prior year, such freight and handling charge revenue was netted against the corresponding selling, general and administrative expenses.

Research and Development Expenses

     Research and development expenses decreased 17.2% to $11.0 million for the three months ended June 28, 2002 from $13.3 million for the three months ended June 29, 2001. The decrease was primarily due to personnel reductions from the global restructuring and optimization plan. In addition, expenses decreased by approximately $0.5 million due to the impact of the divestiture of a non-core business.

Selling, General and Administrative Expenses

     Selling, general and administrative expenses decreased 19.6% to $44.0 million for the three months ended June 28, 2002 from $54.7 million for the three months ended June 29, 2001. The decrease was primarily the result of approximately $0.5 million of facility moving costs, $1.3 million of consulting fees and $12.0 million of severance provisions due to restructuring initiatives incurred in the third quarter of fiscal year 2001 compared to no corresponding expense during the same period in fiscal year 2002. Additionally, the decrease was attributable to the elimination of $2.9 million of expenses incurred in the third quarter of fiscal year 2001, by a non-core business divested in January 2002, combined with the impact of further headcount reductions following the implementation of the global restructuring and optimization plan. The decrease in expenses was partially offset by a compensation charge of $2.9 million related to an employee stock award plan recorded during the third quarter of fiscal year 2002, compared to $1.3 million during the same period in the prior fiscal year. Additionally, the decrease in expenses was offset by approximately $0.9 million of freight and handling charge revenue that was recognized in net sales during the three months ended June 28, 2002. In the prior year, such freight and handling charge revenue was netted against the corresponding selling, general and administrative expenses.

16


Table of Contents

Amortization of Intangible Assets

     Amortization of intangible assets decreased 37.7% to $4.2 million for the three months ended June 28, 2002 from $6.8 million for the three months ended June 29, 2001. The decrease was primarily due to our adoption of SFAS No. 142, “Goodwill and Other Intangible Assets.” The pronouncement requires that periodic amortization of goodwill be ceased, and that annual reviews of the net realizable value of the goodwill need to be performed to determine if an impairment of the goodwill asset value exists. We expect no impairment in goodwill and other intangible assets. Therefore, we recorded no goodwill amortization in accordance with SFAS No. 142 in the third quarter of fiscal year 2002, whereas approximately $2.2 million of goodwill amortization was recorded during the third quarter of fiscal year 2001.

Interest Expense, Net

     Interest expense, net, decreased 35.5% to $7.1 million for the three months ended June 28, 2002 from $11.0 million for the three months ended June 29, 2001. The decrease was primarily due to lower average debt balances and interest rates during the second quarter of fiscal year 2002 compared to the same period of the prior fiscal year.

Other Non-Operating Income (Expense), Net

     Seminis had other non-operating income, including foreign currency gain (loss), net, of $4.0 million for the three months ended June 28, 2002 as compared to other non-operating expense, net, of $2.0 million for the three months ended June 29, 2001. Other non-operating income, net, for the three months ended June 28, 2002 primarily consists of approximately $1.2 million gain from the sale of non-core assets and foreign currency gain of $2.8 million primarily resulting from fluctuation of a strengthened Euro associated with a United States Dollar denominated loan in The Netherlands. Other non-operating expense, net, for the three months ended June 29, 2001, included a foreign currency loss of $1.6 million primarily attributable to a United States Dollar denominated loan in The Netherlands and other expense of $0.5 million relating to the loss from sale of non-strategic assets.

Income Tax Benefit (Expense)

     Income tax benefit was $1.5 million for the three months ended June 28, 2002, compared to $29.5 million income tax expense for the three months ended June 29, 2001. The change in the income tax benefit was the result of net operating loss carryback provisions, the mix of worldwide income tax rates and the establishment of valuation allowances for certain deferred tax assets in fiscal year 2001.

Seasonality

     The seed business is highly seasonal. Generally, net sales are highest in the second fiscal quarter due to increased demand from Northern Hemisphere growers who plant seed in the early spring. We recorded 33.7% of our fiscal year 2001 net sales during our second fiscal quarter. We have historically operated at a loss during the first and third fiscal quarters due to lower sales during such quarters. Our results in any particular quarter should not be considered indicative of those to be expected for a full year.

17


Table of Contents

Liquidity and Capital Resources

     As of September 30, 2000, we were not in compliance with certain covenants of our syndicated credit facility, which gave the lenders the right to accelerate payment of all amounts outstanding under the facility. In December 2000, the lenders granted a waiver with respect to these covenants as of September 30, 2000, December 29, 2000, and March 31, 2001 that extended through April 30, 2001, at which time any defaults would once again arise. As we did not expect to be in compliance with our covenants once the waiver expired, all outstanding borrowings under the credit facility were classified as a current liability as of September 30, 2000.

     In connection with granting the waivers, the lenders agreed to reschedule principal payments within fiscal year 2001. The lenders also accelerated the final maturity of the term loan and the termination date for the revolving credit commitments to June 30, 2002 from June 30, 2004. We were obligated to deliver a financial plan through September 30, 2002, which detailed cash flow projections on a monthly basis as well as proposed alternatives for the refinancing of the syndicated credit facility or recapitalization of the Company.

     In April 2001, we submitted a financial plan to our lenders, detailing operating initiatives that reduced existing infrastructure and working capital requirements. Additionally, the plan identified alternative sources of capital to repay the bank debt within newly defined terms, which may include the sale of non-strategic assets, debt refinancing and additional equity infusions.

     On May 31, 2001, our lenders agreed with the financial plan and the terms to restructure our $310.0 million credit facility. Upon receipt of the amended credit agreement, long-term portions of borrowings were reclassified from current liabilities to long-term debt. Among other things, the amendment extended the final maturity of the credit facility from the previously agreed on date of June 30, 2002 to December 31, 2002, revised principal payment dates under the term loan, instituted a new grid pricing formula to determine interest on borrowings, and revised covenant obligations. Additionally, the amendment requires us to submit monthly reports comparing actual cash flows to projections as well as describing the progress and status of any asset sales.

     Interim principal obligations under the amendment included $19.0 million, $4.0 million, $31.0 million, and $9.0 million due in the first, second, third, and fourth quarters of fiscal year 2002, respectively. As all remaining amounts under the credit facility are due within one year, the $238.7 million of outstanding borrowings under the credit facility have been classified as a current liability as of June 28, 2002.

     We met all required principal and interest payments during fiscal year 2001 and for the nine months ended June 28, 2002, and were in compliance with all of our financial covenants under the amended credit agreement at September 30, 2001, December 28, 2001, March 29, 2002 and June 28, 2002. In October 2001, we completed the sale of an office building in Seoul, South Korea, which generated net proceeds of approximately $20.0 million. We used $19.5 million of the proceeds to pay the scheduled $19.0 million of our syndicated debt in October 2001. We also sold one of our non-core businesses in January 2002, which generated additional proceeds of approximately $17.6 million. We used $13.0 million of the proceeds to prepay our syndicated debt in January 2002 and utilized our operating cash flow to pay the remaining $18.0 million in June 2002. A total of $20.0 million of principal payment was made to the syndicated credit facility in the current quarter. When combined with cash flows expected to be generated from on-going operations and additional proceeds from the sale of non-core assets, we will be able to meet all obligations and covenants under the credit facility through September 30, 2002. We believe we can continue to improve our operating cash flows through aggressive cash collection efforts, disciplined inventory purchases, and lower operating expenses following the global restructuring and optimization plan.

     Whereas we expect to meet our obligations as well as covenant requirements under the amended credit facility through September 30, 2002, we must successfully execute a refinancing or recapitalization plan prior to December 31, 2002 in order to meet the final maturity of the facility. Based on current projections, we will be obligated to pay $229.7 million during the first quarter of fiscal year 2003. We are currently pursuing a refinancing and recapitalization plan which may include negotiation of a new credit facility, placement of new debt securities, and restructuring of our Class C Preferred Stock and additional capital contributions. The Company entered into an exchange agreement with its majority shareholder, Savia S.A. de C.V. as of July 1, 2002 to exchange all of its outstanding Seminis Class C Preferred Stock (including accrued PIK dividends) having a principal value of $120.2 million, Additional Paid-In Capital (including accrued PIK dividends) of $46.7 million and accrued and unpaid cash dividends of $10.0 million into 37.7 million shares of Seminis Class A common stock. The remaining accrued and unpaid cash dividends on the Class C Preferred Stock of $15.0 million will remain due and payable and will be paid in cash by the Company in accordance with the terms of the exchange agreement. On July 3, 2002, the Company received an opinion from UBS Warburg that, as of such date, the number of shares of Class A common stock to be received by Savia in the exchange was fair from a financial point of view to the holders of the Company’s Class A common stock and Class B common stock (in each case other than Savia and its affiliates and other than holders of the Company’s Class B common stock that also hold shares of the Company’s Class B Redeemable preferred stock). The exchange agreement was approved by the Company’s Board of Directors on July 3, 2002, but remains subject to stockholders’ approval. A copy of the opinion of UBS Warburg and a copy of the exchange agreement have been filed as exhibits to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 9, 2002.

18


Table of Contents

However, there can be no assurances that we will be able to successfully complete the refinancing and recapitalization plan. Failure to comply with existing covenants which would make the syndicated debt callable, or our inability to obtain adequate financing with reasonable terms prior to December 31, 2002 could have a material adverse impact on our business, results of operations, or financial condition.

     As a result of the global restructuring and optimization plan we have made significant strides in the enhancement of our cash flow. During the nine months ended June 28, 2002, we generated $2.4 million of positive operating cash flow, which was an increase of $32.2 million compared to the same period in fiscal year 2001. This improvement in cash flow was primarily due to positive impacts of a decrease in operating expenses through a reduction in global headcount and an overall reduction in working capital arising from improved production planning over our inventory levels.

     Capital expenditures increased to $8.8 million for the nine months ended June 28, 2002, from $7.6 million for the same period in the prior fiscal year. The increase was partly due to $4.5 million investment that primarily related to a production facility, which is being utilized to consolidate our South Korean operations and to enhance our growth strategy in the Far East market. Additionally, $1.2 million of capital expenditure was attributable to the expansion of our Hungarian facility in order to consolidate large seed operations in Europe. Other investing activities for the nine months ended June 28, 2002 included approximately $25.8 million in proceeds from the sale of assets, primarily relating to the sale of an office building in Seoul, South Korea, and $17.6 million from the sale of a non-core business.

     We had $4.0 million of accrued dividends relating to Class B Mandatorily Redeemable Preferred Stock at June 28, 2002. These accrued dividends are classified within mandatorily redeemable stock.

     Our total indebtedness as of June 28, 2002 was $297.7 million, of which $238.7 million were borrowings under our syndicated credit facility and we had $15.4 million, $3.7 million, $8.9 million, $7.0 million, and $19.5 million of borrowings by our United States, Chilean, Italian, Spanish, and South Korean subsidiaries, respectively, and $4.5 million of borrowings primarily by other foreign subsidiaries.

     Our exposure to foreign currency fluctuations is primarily due to foreign currency gains or losses that occur from intercompany loans between us and our foreign subsidiaries and from the United States Dollar denominated loan, originated by SVS Holland, B.V., a foreign subsidiary. We do not have any material outstanding hedging contracts as of June 28, 2002.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

     Our market risk disclosures set forth in the 2001 Form 10-K have not changed significantly through the third quarter ended June 28, 2002.

19


Table of Contents

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

     We are involved, from time to time, as a defendant in various lawsuits arising in the normal course of business. We believe that no current claims, individually or in the aggregate, will have a material adverse effect on our business, results of operations, or financial condition.

     As part of the formation of LSL PlantScience, LSL Biotechnologies contributed certain agreements between LSL Biotechnologies and a third party. These agreements contain provisions that permanently restrict the third party from engaging in the development or marketing of open field tomato seeds having long-shelf life characteristics in certain areas of the world, including North America. In September 2000, the Antitrust Division of the United States Department of Justice filed suit in the United States Court for the District of Arizona against LSL PlantScience, LSL Biotechnologies and our company to delete these restrictive provisions. On March 29, 2002, the United States District Court dismissed, without prejudice, the action against LSL PlantScience, LSL Biotechnologies, and us.

     In January 2002, melon growers in Costa Rica notified us that our Dorado melon seeds were infected with Watermelon Fruit Blotch. Growers who purchased the infected Seminis seeds and growers whose crops were infected by the bacteria that spread from crops grown with the infected Seminis seeds have claimed damages against us. The claims related to those growers who purchased Seminis seeds have been settled for approximately $5.8 million, of which, approximately $2.6 million was recovered under our errors and omissions insurance policy and the remainder of the settlement was paid by the Company by July 2002. The claims related to the growers with the infected crops total approximately $5.2 million and we believe these claims are covered under our general liability insurance policy. We have tentatively settled all of these claims and we have advanced approximately $2.1 million to the growers; however, we are unable to finalize the settlement because our general liability insurance carrier has tentatively denied coverage. We are continuing to negotiate with our general liability insurance carrier on this matter. In the event we cannot finalize the settlement, claims could increase above $5.2 million.

Item 6. Exhibits and Reports on Form 8-K

     We filed a Form 8-K on August 9, 2002.

20


Table of Contents

Exhibit Index

     
Exhibit    
Number   Description

 
(a) 1   Form of Underwriting Agreement
(c) 2   Merger Agreement by and between Seminis, Inc., an Illinois corporation and Seminis, Inc., a Delaware corporation
(c) 3.1   Certificate of Incorporation
(c) 3.2   Certificate of Designations of Class A Mandatorily Redeemable Preferred Stock and Class B Mandatorily Redeemable Preferred Stock of Seminis, Inc.
(c) 3.3   Certificate of Designations of Class C Redeemable Preferred Stock of Seminis, Inc.
(c) 3.4   By-Laws
(c) 4.1   Form of Class A Common Stock Certificate
(a) 4.2   Registration Rights Agreement by and among Seminis, Inc. and certain shareholders of Seminis, dated October 1, 1995
(c) 5   Opinion of Milbank, Tweed, Hadley & McCloy LLP
(a) 10.1   Seminis, Inc. 1998 Stock Option Plan
(b) 10.2   Amended and Restated Seminis, Inc. 1998 Stock Option Plan
(a) 10.3   Share Subscription Agreement by and between Seminis, Inc. and Hungnong Seed Co., Ltd., dated June 12, 1998
(c) 10.4   Form of New Credit Facility among Seminis, Inc, Seminis Vegetable Seeds, Inc., SVS Holland B.V., as borrowers, Harris Trust and Savings Bank, individually and as Administrative Agent, Bank of Montreal, individually and as Syndication Agent, and the Lenders from time to time parties thereto, as lenders, dated as of June 28, 1999
(c) 10.5   Form of Letter Agreement between Savia, S.A. de C.V. and Seminis, Inc. dated as of June 21, 1999
(d) 10.6   Second Amendment and Waiver to Credit Agreement dated as of June 28, 1999 among Seminis, Inc., Seminis Vegetable Seeds, Inc., SVS Holland B.V., as borrowers, Harris Trust and Savings Bank, individually and as Administrative Agent, Bank of Montreal, individually and as Syndication Agent, and the Lenders from time to time parties thereto, as Lenders, Dated as of June 29, 2000, effective March 31, 2000
(d) 10.7   Security Agreement Re: Accounts, Inventory and General Intangibles among Seminis, Inc., Seminis Vegetable Seeds, Inc., SVS Holland B.V., as borrowers, Harris Trust and Savings Bank, individually and as Administrative Agent, Bank of Montreal, individually and as Syndication Agent, and the Lenders from time to time parties thereto, as Lenders, dated as of June 29, 2000
(e) 10.8   Interim Waiver Agreement to Credit Agreement dated as of June 28, 1999 among Seminis, Inc., Seminis Vegetable Seeds, Inc., SVS Holland B.V., as borrowers, Harris Trust and Savings Bank, individually and as Administrative Agent, Bank of Montreal, individually and as Syndication Agent, and the Lenders from time to time parties thereto, as Lenders, dated as of September 30, 2000, effective September 30, 2000.
(d) 10.9   Extension of Interim Waiver Agreement to Credit Agreement dated as of June 28, 1999 among Seminis, Inc., Seminis Vegetable Seeds, Inc., SVS Holland B.V., as borrowers, Harris Trust and Savings Bank, individually and as Administrative Agent, Bank of Montreal, individually and as Syndication Agent, and the Lenders from time to time parties thereto, as Lenders, dated as of December 30, 2000, effective December 30, 2000.
(f) 10.10   Modification and Interim Waiver Agreement to Credit Agreement dated as of June 28, 1999 among Seminis, Inc., Seminis Vegetable Seeds, Inc., SVS Holland B.V. as borrowers, Harris Trust and Savings Bank, individually and as Administrative Agent, Bank of Montreal, individually and as Syndication Agent, and the Lenders from time to time parties thereto, as Lenders, dated as of December 29, 2000, effective December 29, 2000.
(g) 10.11   Modification and Interim Waiver Agreement to Credit Agreement dated as of June 28, 1999 among Seminis, Inc., Seminis Vegetable Seeds, Inc., SVS Holland B.V. as borrowers, Harris Trust and Savings Bank, individually and as Administrative Agent, Bank of Montreal, individually and as Syndication Agent, and the Lenders from time to time parties thereto, as Lenders, dated as of April 30, 2001, effective April 30, 2001.
(g) 10.11   Modification and Interim Waiver Agreement to Credit Agreement dated as of June 28, 1999 among Seminis, Inc., Seminis Vegetable Seeds, Inc., SVS Holland B.V. as borrowers, Harris Trust and Savings Bank, individually and as Administrative Agent, Bank of Montreal, individually and as Syndication Agent, and the Lenders from time to time parties thereto, as Lenders, dated as of April 30, 2001, effective April 30, 2001.
(h) 10.12   Modification and Interim Waiver Agreement to Credit Agreement dated as of June 28, 1999 among Seminis, Inc., Seminis Vegetable Seeds, Inc., SVS Holland B.V. as borrowers, Harris Trust and Savings Bank, individually and as Administrative Agent, Bank of Montreal, individually and as Syndication Agent, and the Lenders from time to time parties thereto, as Lenders, dated as of May 31, 2001, effective May 31, 2001.
(i) 10.13   Revision to (h) 10.12
(b) 21   Subsidiaries of Registrant
27.1   Financial Data Schedule
(j) 99.1   Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
(j) 99.2   Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002.


(a)   Incorporated by reference to Seminis’ Form S-1 filed on February 11, 1999.
(b)   Incorporated by reference to Seminis’ Amendment No. 2 to Form S-1 filed on May 27, 1999.
(c)   Incorporated by reference to Seminis’ Amendment No. 3 to Form S-1 filed on June 21, 1999.
(d)   Filed with the June 30, 2000 form 10Q.
(e)   Filed with the September 30, 2000 form 10K.
(f)   Filed with the December 30, 2000 form 10Q.
(g)   Filed with the March 30, 2001 form 10Q.
(h)   Filed with the June 29, 2001 form 10Q.
(i)   Filed with the September 30, 2001 form 10K.
(j)   Filed with the June 28, 2002 form 10Q.

21


Table of Contents

Signatures

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
Date: August 8, 2002   SEMINIS, INC
 
 
    /s/ Eugenio Najera Solorzano
 
  Eugenio Najera Solorzano
President and Chief Operating Officer
(Principal Executive Officer)
     
    /s/ Gaspar Alvarez Martinez
 
  Gaspar Alvarez Martinez
VP WW Corporate Comptroller and Chief Accounting Officer
(Principal Financial and Accounting Officer)

22